New real-world data from Abbott demonstrates a potentially positive impact of GLP-1 drugs on diabetes technology. GLP-1 receptor agonists, like Ozempic and Wegovy, provide therapy for diabetes and weight loss. This therapeutic class, a glucagon-like peptide 1, has proven to lead to improved blood sugar control and weight loss. The drug class continues to grow […]
Patient Monitoring
QT Medical raises $12M Series B for ECG device
QT Medical announced that it raised $12 million in a Series B financing to support its cardiac care technology. Los Angeles-based QT plans for the funding to accelerate its market penetration, global expansion, product development and long-term planning. The company develops cardiac devices for patients with heart disease. Its flagship Personal Cardiac Assistant (PCA 500), […]
Know Labs prices $7M public offering
Know Labs (NYSE:KNW) announced today that it priced an underwritten public offering worth about $7 million in proceeds. Seattle-based Know Labs, which develops a non-invasive glucose monitor, is offering 28 million shares of common stock. It priced the offering at 25¢ per share, with aggregate gross proceeds expected to total $7 million. The company expects […]
Senseonics completes 365-day CGM study cohort
Senseonics (NYSE:SENS) announced today that it completed its ENHANCE pivotal clinical study adult cohort for its 365-day Eversense CGM. Germantown, Maryland-based Senseonics’ ENHANCE study recorded the completed 365-day visit for the final study patient. The study evaluates the year-long implantable continuous glucose monitor in adults. It also has a pediatric cohort (ages 14 to 18), […]
iRhythm launches next-gen Zio monitor, enhanced long-term monitoring service
iRhythm Technologies announced today that it launched its next-generation Zio monitor in the U.S. In the launch, San Francisco-based iRhythm also included an enhanced Zio long-term continuous monitoring (LTCM) service. Zio, the company’s smallest, lightest and thinnest cardiac monitor, aims to enhance the cardiac monitoring experience for patients. The company said its new service enhancements […]
Dexcom, RxFood partner on AI-based nutrition, glucose monitoring for diabetes management
Dexcom (Nasdaq:DXCM) announced that it teamed up with RxFood on a digital diabetes solution for people in Canada. The first-of-its-kind partnership combines Dexcom’s continuous glucose monitoring (CGM) with RxFood’s AI-driven personalized nutrition assessments. The companies aim to introduce an improved digital health solution for people living with diabetes. It integrates food data with insulin dosing, […]
Abbott completes Bigfoot Biomedical acquisition
Abbott announced today that it completed its previously announced acquisition of Bigfoot Biomedical. Pursuant to the terms of the merger agreement, upon completion, Bigfoot became a wholly-owned subsidiary of Abbott. The companies declined to disclose financial terms. Abbott announced on Sept. 5 that it entered into a definitive agreement to acquire the smart insulin management […]
Medtronic wins CE mark for next-gen Simplera CGM with InPen integration
Medtronic announced today that it received CE mark approval for its new Simplera continuous glucose monitor (CGM). The all-in-one, disposable CGM features a simple, two-step insertion process for people with diabetes using multiple daily injections (MDI). Medtronic’s newest no-fingerstick sensor eliminates the need for overtape, too. It seamlessly integrates with the InPen smart insulin pen […]
Abbott, WeightWatchers unveil connected diabetes app
Abbott and WeightWatchers today announced the availability of a connected app for people living with diabetes. In August 2022, the companies announced a collaboration to integrate continuous glucose monitoring (CGM) with the WW diabetes-tailored plan. The integrated offering provides a mobile experience with information and insights needed for those with diabetes. It helps to make healthy […]
Beacon Biosignals wins FDA nod for wearable sleep monitor
Beacon Biosignals announced today that it received FDA 510(k) clearance for its Dreem 3S wearable electroencephalogram (EEG) headband. The Boston-based company developed Dreem 3S with integrated machine-learning algorithms. The advanced wearable headband captures EEG data from the brain to monitor sleep architecture and aid in diagnosing disturbed sleep. Beacon Biosignals says its easy-to-use device makes […]
Dexcom One CGM sensor launches in France with reimbursement
Dexcom recently announced the availability of its Dexcom One real-time continuous glucose monitor (CGM) in France. The availability of the real-time CGM sensor comes via reimbursement. It brings the technology to half a million more people with diabetes in France. The company secured access to the platform for all patients two years and older with […]
